Ibuprofen transdermal - BioChemics

Drug Profile

Ibuprofen transdermal - BioChemics

Alternative Names: BC-IBU-CH-001; Ibuprofen-VALE cream

Latest Information Update: 31 Jul 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator BioChemics
  • Class Antirheumatics; Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Osteoarthritis

Most Recent Events

  • 31 Jul 2015 No recent reports on development identified - Phase-II for Osteoarthritis in Switzerland (Transdermal)
  • 11 Feb 2014 Biomarkers information updated
  • 07 Dec 2011 Efficacy and adverse events data from a Phase-II trial in Osteoarthritis released by BioChemics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top